Solopore™ is a new, better, nanomechanical cell transfection approach that outperforms the prevailing non-viral approaches (like electroporation) and mitigates the…
It follows only 6 weeks after VVP’s first investment meant to accelerate the commercialization of Basilard BioTech’s next generation nanomechanical…